Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis

Clinical trial NCT06567717 · RECRUITING

Trial details

NCT number: NCT06567717
Sponsor: Cedars-Sinai Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2025-11-03
Primary completion: 2027-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.